Fact CheckerSign in

NCT04652713Completed

Breakfast for Young Women

Source: ClinicalTrials.gov · Last updated 9 May 2024

Brief summary (registry, in English)

Investigators will in a crossover study test the health effects of eating a dairy-based protein-rich breakfast, isocaloric carbohydrate-rich breakfast or no breakfast in young overweight women. Determination of satiety and hunger using visual analog scores (VAS), collection of blood samples and 2x 24 hours food logs will be collected.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
26 Nov 2020
Start date
24 Nov 2020
Primary completion date
1 Sept 2022
Lead sponsor
University of Aarhus
Diseases
Obesity
NCT number
NCT04652713

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 24 Nov 2020 to the primary completion date, 1 Sept 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • illness and use of medication affecting the study outcomes
  • allergy towards lactose or gluten
  • eating disorder

Other

  • weightloss/gain \>5kg the last 6 months
  • dieting
  • pregnancy
  • breast feeding
  • unable to speak and understand danish

Who the study is looking for

  • Body mass index \> 25
  • Age 18-25 years
  • Regular exercise \< 5 hour per week

Age in the registry: 18 years to 30 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aarhus University, Department for Public Health, Section for Sport Science
Coordinator of this site? Confirm its status
AarhusDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.